🟢 HCW Biologics Inc is trading 5.9% up today on technical rebound after dilution-driven selloff

HCW Biologics Inc is trading 5.9% up today at $1.25 on a technical rebound as investors digest earlier dilution concerns following a sharp decline linked to a recent private placement.

• The upward move is viewed as a corrective bounce after the stock faced pressure from a share registration statement tied to its recent financing.
• The gain appears to be driven by technical factors rather than fresh fundamental news or broader market strength.
• The stock's performance stands out as major market indices are currently trading slightly lower.